When AI designs a drug, who gets the credit? | HappeningNow.news

Technology · 3 views

When AI designs a drug, who gets the credit?

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastical…

Source MIT Technology Review Story Brief Updated 1h 09m ago
Story intelligence Beta
Confidence Limited Single-outlet story
Views 3 Community interest
Read time 1 min ~70 words

Story Brief

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think of, potentially speeding the race to new cures.

Read full article on Technologyreview

More from Technology

Continue reading recent Technology coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page